Search for: "Pfizer Pharmaceutic, Inc."
Results 621 - 640
of 664
Sorted by Relevance
|
Sort by Date
25 Jul 2007, 12:42 pm
Patent and Trademark Office (USPTO) to grant a request for reexamination of four key HIV/AIDS drug patents held by Gilead Sciences Inc. [read post]
9 Aug 2011, 4:30 am
Pfizer, 232 F.R.D. 360 (C.D. [read post]
2 Mar 2022, 10:39 am
For example, Holmes’ added the Pfizer logo to company reports, which led large investors, like Walgreens, to believe that the blood tests had been validated by the pharmaceutical giant. [read post]
19 Apr 2013, 5:35 pm
Ortho Pharmaceutical Corp. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
13 Sep 2007, 10:48 am
Jude Medical, Inc., 425 F.3d 1116, 1119-21 (8th Cir. 2005), and Castano v. [read post]
3 Mar 2012, 5:36 pm
Pfizer, 196 F. [read post]
27 Mar 2018, 4:00 am
Pfizer Canada Inc. 2017 FC 826, the Federal Court said that the funding agreement is privileged and refused to order disclosure of the complete unredacted agreement to the defendant. [read post]
5 Feb 2009, 12:19 pm
Pfizer, Inc., 381 F. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
20 Jul 2011, 1:27 pm
Pfizer, Inc., 773 N.E.2d 720 (Ill. [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
1 May 2024, 1:18 pm
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will… [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
3 Sep 2009, 1:24 am
District Judge Vanessa Bryant ruled on Aug. 27 that Boehringer Ingelheim Pharmaceuticals Inc. violated the Age Discrimination in Employment Act by forcing Robert Raymond, chief patent counsel and vice president for intellectual property, to retire at age 65 in 2004. [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
13 Apr 2014, 8:59 am
Pfizer Canada Inc., [2012] 3 S.C.R. 625 The patent system is based on a “bargain”, or quid pro quo: the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge. [read post]
